pI: 8.974 |
Length (AA): 252 |
MW (Da): 28604 |
Paralog Number:
0
Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128077)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G27340 | N-acetylglucosaminylphosphatidylinositol de-N-acetylase family protein |
Arabidopsis thaliana | AT3G58130 | N-acetylglucosaminylphosphatidylinositol de-N-acetylase family protein |
Babesia bovis | BBOV_III007080 | N-acetylglucosaminyl-phosphatidylinositol de-n-acetylase, putative |
Brugia malayi | Bm1_48430 | Uncharacterized LmbE-like protein, COG2120 containing protein |
Candida albicans | CaO19.4903 | N-acetylglucosaminylphosphatidylinositol deacetylase |
Candida albicans | CaO19.12368 | N-acetylglucosaminylphosphatidylinositol deacetylase |
Caenorhabditis elegans | CELE_Y52B11C.1 | Protein Y52B11C.1 |
Cryptosporidium parvum | cgd7_700 | N-acetylglucosaminyl-phosphatidylinositolde-N-acetylase |
Dictyostelium discoideum | DDB_G0293136 | phosphatidylinositol glycan, class L |
Drosophila melanogaster | Dmel_CG4433 | CG4433 gene product from transcript CG4433-RD |
Echinococcus granulosus | EgrG_000245500 | N acetylglucosaminyl phosphatidylinositol |
Entamoeba histolytica | EHI_015270 | N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase, putative |
Echinococcus multilocularis | EmuJ_000245500 | N acetylglucosaminyl phosphatidylinositol |
Giardia lamblia | GL50803_14236 | hypothetical protein |
Homo sapiens | ENSG00000108474 | phosphatidylinositol glycan anchor biosynthesis, class L |
Leishmania braziliensis | LbrM.09.0060 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Leishmania donovani | LdBPK_090060.1 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Leishmania infantum | LinJ.09.0060 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Leishmania major | LmjF.09.0040 | N-acetyl-D-acetylglucosaminylphosphatidylinositol deacetylase |
Leishmania mexicana | LmxM.09.0040 | N-acetylglucosaminyl-phosphatidylinositol deacetylase |
Loa Loa (eye worm) | LOAG_01808 | phosphatidylinositol glycan anchor biosynthesis protein |
Mus musculus | 327942 | phosphatidylinositol glycan anchor biosynthesis, class L |
Mycobacterium tuberculosis | Rv0323c | Conserved hypothetical protein |
Neospora caninum | NCLIV_028260 | hypothetical protein |
Oryza sativa | 4337416 | Os04g0678800 |
Plasmodium berghei | PBANKA_1123600 | N-acetylglucosaminylphosphatidylinositol deacetylase, putative |
Plasmodium falciparum | PF3D7_0624700 | N-acetylglucosaminylphosphatidylinositol deacetylase, putative |
Plasmodium vivax | PVX_114344 | N-acetylglucosaminylphosphatidylinositol deacetylase, putative |
Plasmodium yoelii | PY06379 | probable n-acetylglucosaminyl-phosphatidylinositol de-n-acetylase |
Saccharomyces cerevisiae | YMR281W | Gpi12p |
Schistosoma japonicum | Sjp_0304740 | ko:K03434 N-acetylglucosaminylphosphatidylinositol deacetylase [EC3.5.1.89], putative |
Schistosoma mansoni | Smp_035080 | N-acetylglucosaminyl-phosphatidylinositol de-n-acetylase |
Trypanosoma brucei gambiense | Tbg972.11.13520 | N-acetylglucosaminyl-phosphatidylinositol deacetylase, putative |
Trypanosoma brucei | Tb927.11.12080 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Trypanosoma congolense | TcIL3000.11.12710 | N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase |
Trypanosoma cruzi | TcCLB.504005.20 | N-Acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase, putative |
Trypanosoma cruzi | TcCLB.511481.40 | N-Acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase, putative |
Toxoplasma gondii | TGME49_258110 | N-acetylglucosaminylphosphatidylinositol deacetylase |
Toxoplasma gondii | TGME49_258100 | TPR repeat region protein |
Theileria parva | TP04_0615 | N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu326 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.01.3900 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.3900 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.3900 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.3900 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YMR281W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1123600 | Plasmodium berghei | Essential | plasmo |
TGME49_258110 | Toxoplasma gondii | Probably essential | sidik |
TGME49_258100 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | single cell organism (CARO:0000064) | bloodstream stage (PLO:0040) | inferred from loss-of-function mutant phenotype (ECO:0000016) | Trypanosoma brucei brucei | No drug identifiers listed for this gene. |
Annotator: | ts4@sanger.ac.uk. | Comment: | . | References: | 12364327 | |
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | single cell organism (CARO:0000064) | bloodstream stage (PLO:0040) | inferred from bioassay (ECO:0000094) | Trypanosoma brucei brucei | No drug identifiers listed for this gene. |
Annotator: | ts4@sanger.ac.uk. | Comment: | Drug: GlcNCONH2-beta-PI; Drug: GlcNCONH2-(2-O-octyl)-PI. . | References: | 11432820 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.